Skip to Main Content

Paper Details

Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
Cell
143
2021
Baricitinib, COVID, COVID-19, IFN, JAK1, JAK2, SARS, SARS-, SARS-CoV, SARS-CoV-2, T, T cell, Type I interferon, baricitinib, hypercytokinemia, inflammation, inflammatory cells, lung, lung macrophage, macrophage inflammation, neutrophil, rhesus macaque, rhesus macaques
Author NameAffiliation
Michael NekorchukVaccine and Gene Therapy Institute, Oregon Health & Science University
Sudhir Pai KasturiYerkes National Primate Research Center, Emory University
Rafick-Pierre SekalyCase Western Reserve University
Jacob D EstesVaccine and Gene Therapy Institute, Oregon Health & Science University, USA Oregon National Primate Research Center
Steven E BosingerYerkes National Primate Research Center, Emory University
  • 1 - 5

Datasets

Release 1.2